|
|
 |
|
Viewing report
|
|
|
|
Drug Truths: Dispelling the Myths About Pharma R & D
John Wiley and Sons Ltd, Nov 2008, Pages: 136
This book answers the questions about the process and costs of pharmaceutical R & D in a compelling narrative focused on the discovery and development of important new medicines. It gives an insider's account of the pharmaceutical industry drug discovery process, the very real costs of misperceptions about the industry, the high stakes--both economic and scientific--of developing drugs, the triumphs that come when new compounds reach the market and save lives, and the despair that follows when new compounds fail. In the book, John LaMattina, former president of Pfizer Global Research and Development, weaves themes critical to a vital drug discovery environment in the context. This is a story that Dr. LaMattina is uniquely qualified to tell.
Authors bio:
John L. LaMattina, PhD, retired as president of Pfizer Global Research and Development in 2007 where he managed more than 13,000 scientists and support professionals in the United States, Europe, and Asia. Dr. LaMattina has received numerous awards including an Honorary Doctor of Science degree from the University of New Hampshire.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India
Genomics in Drug Discovery and Development
New Drug Discovery and Development
Drug Discovery and Development, Volume 2, Drug Development
Targeting Kinases for Drug Discovery
Overview of the European Drug Discovery Market
Drug Discovery Research: New Frontiers in the Post-Genomic Era
Innovations in Bioinformatics: Emerging Tools for Drug Discovery and Development
Navigating the Drug Discovery Landscape: A Strategic Overview of Pharmaceutical R&D
Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
Cell-Based Assays for Drug Discovery
|
|
|
|
